Search filters

List of works by Ewa Jabłońska

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia.

scientific article published on 30 March 2018

Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases

scientific article published on 01 March 2008

Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.

scientific article published on 11 July 2017

FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.

scientific article published on 19 November 2015

FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism

scientific article

FOXO1 transcription factor: a critical effector of the PI3K-AKT axis in B-cell development

scientific article

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy

scientific article

MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells.

scientific article published on 06 October 2016

Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.

scientific article published on 17 April 2018

SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism

scientific article published on 06 November 2020